XML 43 R20.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCK-BASED COMPENSATION
 12 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
STOCK COMPENSATION PLANS
The Company has three active stock-based compensation plans at June 30, 2024 as shown in the table below:
Date ApprovedName of PlanType of PlanAuthorized
Shares
June 20142014 Stock Option Incentive PlanStock options750,000 
June 20152015 Equity Incentive PlanStock & stock options1,250,000 
April 20182018 Equity Incentive PlanStock & stock options10,000,000 
12,000,000 

As of June 30, 2024, the Company had reserved shares of Common Stock for future issuance for the following:
Common StockReserved Shares
Conversions of Preferred Stock and cumulative Preferred Stock dividends95,558 
Issuance of shares to former executive upon the occurrence of a Cantaloupe transaction (1)
140,000 
Total shares reserved for future issuance235,558 
(1)Represents 140,000 shares issuable to our former executive upon the occurrence of a "USA Transaction" as such term is defined in the stock agreement.
As of June 30, 2024, the Company had the following shares available for issuance under the respective incentive plans:
Incentive Plan
Available Options
Issuance under 2014 Stock Option Incentive Plan15,687 
Issuance under 2015 Equity Incentive Plan369,157 
Issuance under 2018 Equity Incentive Plan4,170,267 
Total options available for future issuance
4,555,111 
STOCK OPTIONS
Stock options are granted at exercise prices equal to the fair market value of the Company's common stock at the date of grant. The options typically vest over a three-year period and each option, if not exercised or terminated, expires on the seventh anniversary of the grant date.
The Company estimates the grant date fair value of the stock options with service conditions (i.e., a condition that requires an employee to render services to the Company for a stated period of time to vest) it grants using a Black-Scholes valuation model. The Company’s assumption for expected volatility is based on its historical volatility data related to market trading of its own common stock. The Company uses the simplified method to determine expected term, as the Company does not have adequate historical exercise and forfeiture behavior on which to base the expected life assumption. The dividend yield assumption is based on dividends expected to be paid over the expected life of the stock option. The risk-free interest rate assumption is determined by using the U.S. Treasury rates of the same period as the expected option term of each stock option.
The fair value of options granted during the years ended June 30, 2024, 2023, and 2022 was determined using the following assumptions:
For the year ended June 30,
202420232022
Expected volatility
52.6 - 69.7%
74.6 - 77.6%
73.2 - 74.6%
Expected life (years)
4.2 - 4.5
4.4 - 4.6
4.5 - 4.6
Expected dividends0.0%0.0%0.0%
Risk-free interest rate
4.0 - 4.4%
2.7 - 4.1%
1.0 - 2.9%

The following tables provide information about outstanding options for the years ended June 30, 2024, 2023, and 2022:
For the year ended June 30, 2024
Number of OptionsWeighted Average
Exercise Price		Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
(in thousands)
Outstanding options, beginning of year
3,873,632 $6.35 5.1$7,595 
Granted175,000 $6.92 
Exercised(18,334)$6.06 $— 
Forfeited(29,799)$6.90 
Expired(28,665)$4.40 
Outstanding options, end of year
3,971,834 $6.63 4.3$3,582 
Exercisable options, end of year
2,602,259 $7.28 3.8$1,085 

For the year ended June 30, 2023
Number of OptionsWeighted Average
Exercise Price		Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
(in thousands)
Outstanding options, beginning of year
3,529,833 $7.41 4.5$194 
Granted1,720,000 $4.61 
Exercised— $— $— 
Forfeited(1,376,201)$6.86 
Expired— $— 
Outstanding options, end of year
3,873,632 $6.35 5.1$7,595 
Exercisable options, end of year
1,341,466 $7.26 3.9$1,536 

For the year ended June 30, 2022
Number of OptionsWeighted Average
Exercise Price		Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
(in thousands)
Outstanding options, beginning of year
2,952,092 $6.97 5.6$14,419 
Granted904,500 $8.86 
Exercised(121,248)$6.30 $(53)
Forfeited(205,511)$8.09 
Expired— $— 
Outstanding options, end of year
3,529,833 $7.41 4.5$194 
Exercisable options, end of year
1,538,302 $6.79 4.5$183 
The weighted average grant date fair value per share for the Company's stock options granted during the years ended June 30, 2024, 2023, and 2022 was $4.02, $2.89, and $5.12, respectively. The total fair value of stock options vested during the years ended June 30, 2024, 2023, and 2022 was $4.5 million, $3.8 million, and $3.0 million, respectively.
Performance based awards
The Company has awarded stock options to certain executives which vest each year over a three to four-year period. These stock options are also subject to the achievement of performance goals to be established by the Company's Board for each fiscal
year.

The Compensation Committee of the Board of Directors established the performance metrics as a price target for the trading price of the Company’s common stock in each applicable fiscal year. The price target is achieved if the average closing price of the common stock during any consecutive 30-trading-day period during the applicable fiscal year meets or exceeds: (i) $10.50 in the case of fiscal year 2021; (ii) $13.50 in the case of fiscal year 2022; (iii) $16.50 in the case of fiscal year 2023; and (iv) $19.50 in the case of fiscal year 2024. If at least 80% of the performance goals for an applicable fiscal year are achieved, the Compensation Committee may determine that the portion of the option eligible to vest based on such fiscal year’s performance will vest on a prorated basis. In so determining, the Compensation Committee will consider the Company’s performance relative to its market competitors and any other considerations deemed relevant by the Compensation Committee. The Compensation Committee’s guideline is generally that for every percentage point the achieved price falls below the price target, the percentage of the performance options eligible to vest in respect of the applicable fiscal year should be reduced by 2%, but the Compensation Committee may vary this formula in its sole discretion.

For these performance-based awards that provide discretion to the Compensation Committee, a mutual understanding of the key terms and conditions between the Company and the employees have not yet been met and a grant date has not been established. When the service period begins prior to the grant date, the Company begins recognizing compensation cost before there is a grant date. The Company estimates the award's fair value at each reporting period for these equity classified awards, until the grant date, utilizing a Monte Carlo simulation valuation model. The total expense recognized during the year ended June 30, 2024 for these awards was $0.1 million. For the year ended June 30, 2023, the total net benefit recognized for these awards was $0.8 million, primarily as a result of reversing unvested grants for terminated executives during the period.

COMMON STOCK GRANTS

The Company makes annual grants of restricted shares of common stock to executive officers pursuant to long-term stock incentive plans (“LTIPs”) which vest annually, typically over three years.

The Company also grants restricted stock units ("RSU"s) to members of the board of directors as compensation for their service on the board as well as to employees as additional compensation. These stock awards typically vest over a one to three-year period.

A summary of the status of the Company’s nonvested common shares and RSUs as of June 30, 2024, 2023, and 2022, and changes during the years then ended is presented below:
SharesWeighted-Average
Grant-Date
Fair Value
Nonvested at June 30, 2021137,846 $9.57 
Granted507,729 $7.33 
Vested(101,515)$10.34 
Forfeited(95,152)$8.89 
Nonvested at June 30, 2022448,908 $7.00 
Granted346,346 $5.41 
Vested(274,011)$5.96 
Forfeited(97,342)$8.27 
Nonvested at June 30, 2023423,901 $6.08 
Granted439,363 $6.72 
Vested(311,093)$6.38 
Forfeited(4,207)$7.58 
Nonvested at June 30, 2024547,964 $6.41 
STOCK-BASED COMPENSATION EXPENSE

The Company applies the fair value method to recognize compensation expense for stock-based awards. Using this method, the estimated grant-date fair value of the award is recognized over the requisite service period using the accelerated attribution method. The Company accounts for forfeitures as they occur.

A summary of the Company's stock-based compensation expense recognized during the years ended June 30, 2024, 2023, and 2022 is as follows:
($ in thousands)For the year ended June 30,
Award type202420232022
Stock options$2,992 $2,967 $4,424 
Stock grants2,117 1,770 1,824 
Total stock-based compensation expense$5,109 $4,737 $6,248 

The Company recognized tax benefits of $0.5 million, $1.4 million, and $0.6 million related to stock compensation expense for the years ended June 30, 2024, 2023, and 2022, respectively.

A summary of the Company's unrecognized stock-based compensation expense as of June 30, 2024 is as follows:
As of June 30, 2024
Award typeUnrecognized Expense
(in thousands)		Weighted Average Recognition Period
(in years)
Stock options$1,566 1.3
Stock grants$2,225 1.5